Clik here to view.
Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First...
September 4, 2014 Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) at a dose of 2 mg/kg...
View ArticleClik here to view.
Karyopharm Announces Orphan Designation Granted by FDA for Selinexor...
Karyopharm Announces Orphan Designation Granted by FDA for Selinexor (KPT-330) in Multiple Myeloma Newton, Mass. – January 8, 2015 – Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage...
View ArticleClik here to view.
Emerge Health – innovative Australian pharmaceutical company
Emerge Health is an innovative Australian pharmaceutical company focused on providing access to specialised medicines into the hospital sector. Emerge Health is dedicated to supporting patients with...
View ArticleClik here to view.
World Orphan Drug Congress LIVE: Commercialization
Back in our main conference room, our commercialization segment of the afternoon began. Mark Rothera Chief Commercial Officer of PTC Therapeutics spoke about launching the 1st therapy for DMD- a 16...
View ArticleClik here to view.
What are the latest trends in Orphan Drugs?
What’s hot in Orphan Drugs? Download our “Trends in Orphan Drugs eBook” now > This E-book is a compilation of the top 11 trends in orphan drugs. Download this eBook now to see our examination of...
View ArticleClik here to view.
[PRESS RELEASE] Neurology Reviews® Publishes the 2nd Annual Rare Neurological...
Neurology Reviews® Publishes the 2nd Annual Rare Neurological Disease Special Report™ ~ Published in February in honor of Rare Disease Day—February 29, 2016 ~ Parsippany, NJ – February 29, 2016 – The...
View ArticleClik here to view.
HEALTHCARE STAKEHOLDERS ADDRESS COMPLEX ISSUES OF SELF-MANAGEMENT IN RARE...
Atlantis Healthcare Leads Discussions at World Orphan Drug Congress on Using Health Psychology to Understand Personalized Patient Needs Auckland/London/Cranford, NJ – Treatment nonadherence doesn’t...
View ArticleClik here to view.
Keynote announced – FDA Commissioner Dr. Robert Califf to tackle precision...
NEW YORK – Dr. Robert Califf, the recently appointed Commissioner of the U.S. Food and Drug Administration (FDA), will be presenting the opening address on the second day of the inaugural World...
View ArticleClik here to view.
Industry pushes Presidential Candidates to support Precision Medicine
NEW YORK, Oct. 3, 2016- The following is an open letter from World Precision Medicine Congress USA 2016 / Terrapinn Inc. Copies of the letter will be hand delivered to the Campaign Headquarter of...
View ArticleClik here to view.
Do’s and Don’ts for Orphan Drug Support Programs
Getting personal with rare disease patients. By Nancy Pilcher, RN November 28, 2016 Complex. It’s the word most often associated with the orphan drug market. Commercialization success for rare disease...
View Article
